Literature DB >> 10355729

Effect of pig-specific cytokines on mobilization of hematopoietic progenitor cells in pigs and on pig bone marrow engraftment in baboons.

T Kozlowski1, R Monroy, M Giovino, R J Hawley, R Glaser, Z Li, D H Meshulam, T R Spitzer, D K Cooper, D H Sachs.   

Abstract

Mixed hematopoietic chimerism has been found to be a requirement for achieving specific immunologic hyporesponsiveness. Some of the requirements for in vitro and in vivo coexistence of discordant hematopoietic systems in the pig-to-baboon (or human) model have been investigated. We have tested the efficacy of pig-specific cytokines (PSC) (IL3, SCF, GM-CSF) in the mobilization of porcine bone marrow (BM) progenitors in vivo (i) in the pig and (ii) in baboons that underwent a conditioning regimen and porcine BM transplantation. In a preliminary in vitro study, porcine BM cells were incubated in various media to assess the effect of human plasma on pig progenitors in a colony-forming unit (CFU) assay. In in vivo studies, four pigs received PSC and one control pig did not. Six baboons underwent natural antibody removal, with subsequent pig BM transplantation. Four of these six underwent nonmyeloablative (n=2) or myeloablative (n=2) conditioning and all received PSC treatment. Two baboons did not receive PSC, one of which underwent a nonmyeloablative regimen. Sequential blood samples and BM biopsies in pigs and baboons were analyzed by CFU assay for the detection of porcine cells. Baboon samples were analyzed by polymerase chain reaction (PCR) to detect porcine DNA. In the case of the in vitro tests, colony forming by porcine progenitors was not inhibited by media containing human plasma and for the in vivo tests, PSC increased the number of progenitors in pig BM; mobilization of progenitors into the peripheral blood was observed. PSC-treated baboons which experienced transient depletion of leukocytes < 1,000/ml (as an effect of the conditioning regimen) had porcine BM cells detectable by PCR for as long as day 316 after BM transplantation. In conclusion we found that: (i) under the conditions of these studies, in vitro porcine progenitor cell growth was not inhibited by human plasma containing natural antibody and complement; (ii) PSC treatment led to an increased number of progenitors in pig BM and peripheral blood; (iii) the combination of an effective conditioning regimen and treatment with PSC was capable of inducing long-term survival of pig progenitors in baboons, although only a low level of engraftment was achieved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355729     DOI: 10.1034/j.1399-3089.1999.00002.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  10 in total

1.  Occurrence of specific humoral non-responsiveness to swine antigens following administration of GalT-KO bone marrow to baboons.

Authors:  Adam Griesemer; Fan Liang; Atsushi Hirakata; Erica Hirsh; Diana Lo; Masayoshi Okumi; Megan Sykes; Kazuhiko Yamada; Christene A Huang; David H Sachs
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

Review 2.  Current progress in xenogeneic tolerance.

Authors:  Kazuhiko Yamada; Joseph Scalea
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

3.  Expression and purification of non-N-glycosylated porcine interleukin 3 in yeast Pichia pastoris.

Authors:  Christina E Hermanrud; Vimukthi Pathiraja; Abraham Matar; Raimon Duran-Struuck; Rebecca L Crepeau; Srimathi Srinivasan; David H Sachs; Christene A Huang; Zhirui Wang
Journal:  Protein Expr Purif       Date:  2011-12-01       Impact factor: 1.650

4.  Mixed chimerism and tolerance without whole body irradiation in a large animal model.

Authors:  Y Fuchimoto; C A Huang; K Yamada; A Shimizu; H Kitamura; R B Colvin; V Ferrara; M C Murphy; M Sykes; M White-Scharf; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  High incidence of xenogenic bone marrow engraftment in pig-to-baboon intra-bone bone marrow transplantation.

Authors:  M Tasaki; I Wamala; A Tena; V Villani; M Sekijima; V Pathiraja; R A Wilkinson; S Pratts; T Cormack; E Clayman; J S Arn; A Shimizu; J A Fishman; D H Sachs; K Yamada
Journal:  Am J Transplant       Date:  2015-02-12       Impact factor: 8.086

Review 6.  Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy.

Authors:  David H Sachs; Megan Sykes; Kazuhiko Yamada
Journal:  Transpl Immunol       Date:  2008-12-06       Impact factor: 1.708

Review 7.  The porcine lung as a potential model for cystic fibrosis.

Authors:  Christopher S Rogers; William M Abraham; Kim A Brogden; John F Engelhardt; John T Fisher; Paul B McCray; Geoffrey McLennan; David K Meyerholz; Eman Namati; Lynda S Ostedgaard; Randall S Prather; Juan R Sabater; David Anthony Stoltz; Joseph Zabner; Michael J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-16       Impact factor: 5.464

Review 8.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.

Authors:  Abraham J Matar; Rebecca L Crepeau; Vimukthi Pathiraja; Simon Robson; Jay A Fishman; Thomas R Spitzer; David H Sachs; Christene A Huang; Raimon Duran-Struuck
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

Review 10.  Xenotransplantation tolerance: applications for recent advances in modified swine.

Authors:  Nathaly P Llore; Karina A Bruestle; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2018-12       Impact factor: 2.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.